Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling

被引:47
作者
Auer, A
von Blume, J
Sturany, S
von Wichert, G
Van Lint, J
Vandenheede, J
Adler, G
Seufferlein, T [1 ]
机构
[1] Med Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany
[2] Catholic Univ Louvain, Afd Biochem, B-3000 Louvain, Belgium
关键词
D O I
10.1091/mbc.E05-03-0251
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Protein kinase D2 (PKD2) belongs to the PKD family of serine/threonine kinases that is activated by phorbol esters and G protein-coupled receptors (GPCRs). Its C-terminal regulatory domain comprises two cysteine-rich domains (C1a/C1b) followed by a pleckstrin homology (PH) domain. Here, we examined the role of the regulatory domain in PKD2 phorbol ester binding, catalytic activity, and subcellular localization: The PH domain is a negative regulator of kinase activity. C1a/C1b, in particular C1b, is required for phorbol ester binding and gastrin-stimulated PKD2 activation, but it has no inhibitory effect on the catalytic activity. Gastrin triggers nuclear accumulation of PKD2 in living AGS-B cancer cells. C1a/C1b, not the PH domain, plays a complex role in the regulation of nucleocytoplasmic shuttling: We identified a nuclear localization sequence in the linker region between C1a and C1b and a nuclear export signal in the C1a domain. In conclusion, our results define the critical components of the PKD2 regulatory domain controlling phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling and reveal marked differences to the regulatory properties of this domain in PKD1. These findings could explain functional differences between PKD isoforms and point to a functional role of PKD2 in the nucleus upon activation by GPCRs.
引用
收藏
页码:4375 / 4385
页数:11
相关论文
共 31 条
[11]   Protein kinase D activation by mutations within its pleckstrin homology domain [J].
Iglesias, T ;
Rozengurt, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :410-416
[12]   Dissimilar phorbol ester binding properties of the individual cysteine-rich motifs of protein kinase D [J].
Iglesias, T ;
Matthews, S ;
Rozengurt, E .
FEBS LETTERS, 1998, 437 (1-2) :19-23
[13]   CHARACTERIZATION OF THE CYSTEINE-RICH REGION OF THE CAENORHABDITIS-ELEGANS PROTEIN UNC-13 AS A HIGH-AFFINITY PHORBOL ESTER RECEPTOR - ANALYSIS OF LIGAND-BINDING INTERACTIONS, LIPID COFACTOR REQUIREMENTS, AND INHIBITOR SENSITIVITY [J].
KAZANIETZ, MG ;
LEWIN, NE ;
BRUNS, JD ;
BLUMBERG, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10777-10783
[14]   Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1 [J].
Kudo, N ;
Wolff, B ;
Sekimoto, T ;
Schreiner, EP ;
Yoneda, Y ;
Yanagida, M ;
Horinouchi, S ;
Yoshida, M .
EXPERIMENTAL CELL RESEARCH, 1998, 242 (02) :540-547
[15]   Studying protein dynamics in living cells [J].
Lippincott-Schwartz, J ;
Snapp, E ;
Kenworthy, A .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (06) :444-456
[16]   Recruitment of protein kinase D to the trans-Golgi network via the first cysteine-rich domain [J].
Maeda, Y ;
Beznoussenko, GV ;
Van Lint, J ;
Mironov, AA ;
Malhotra, V .
EMBO JOURNAL, 2001, 20 (21) :5982-5990
[17]   The protein kinase complement of the human genome [J].
Manning, G ;
Whyte, DB ;
Martinez, R ;
Hunter, T ;
Sudarsanam, S .
SCIENCE, 2002, 298 (5600) :1912-+
[18]   Protein kinase D2 mediates activation of nuclear factor κB by Bcr-Abl in Bcr-Abl+ human myeloid leukemia cells [J].
Mihailovic, T ;
Marx, M ;
Auer, A ;
Van Lint, J ;
Schmid, M ;
Weber, C ;
Seufferlein, T .
CANCER RESEARCH, 2004, 64 (24) :8939-8944
[19]  
NISHI K, 1994, J BIOL CHEM, V269, P6320
[20]   Mechanism of persistent protein kinase D1 translocation and activation [J].
Oancea, E ;
Bezzerides, VJ ;
Greka, A ;
Clapham, DE .
DEVELOPMENTAL CELL, 2003, 4 (04) :561-574